IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AMONG PATIENTS WITH RESOLUTION OF ENTHESITIS AND/OR DACTYLITIS: POST HOC ANALYSES FROM THE KEEPSAKE 1 AND 2 TRIALS OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kwatra, S. [1 ]
Khattri, S. [2 ]
Amin, A. [3 ]
Liu, R. [4 ]
Padilla, B. [4 ]
Soliman, A. M. [4 ]
Kaplan, B. [4 ]
Mcgonagle, D. [5 ,6 ]
机构：
[1] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD USA
[2] Mt Sinai, Dept Dermatol, New York, NY USA
[3] Northwestern Med Dermatol, Dermatol, Chicago, IL USA
[4] AbbVie, Dept Immunol, N Chicago, IL USA
[5] Univ Washington, Div Rheumatol, Seattle, WA USA
[6] Univ Leeds, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Spondyloarthritis; Enthesitis; Pain;
D O I：
10.1136/annrheumdis-2023-eular.2790
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0957
引用
收藏
页码：1696 / 1697
页数：2
相关论文
共 50 条
  • [1] Improvements in Patient-Reported Outcomes Among Patients With Resolution of Enthesitis and/or Dactylitis: Post hoc Analyses From the KEEPsAKE 1 and 2 Trials of Risankizumab in Patients With Active Psoriatic Arthritis
    Kwatra, Shawn G.
    Khattri, Saakshi
    Amin, Ahmad Z.
    Liu, Ran
    Padilla, Byron
    Soliman, Ahmed M.
    Kaplan, Blair
    McGonagle, Dennis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB55 - AB55
  • [2] Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials
    Kwatra, Shawn G.
    Khattri, Saakshi
    Amin, Ahmad Z.
    Ranza, Roberto
    Kaplan, Blair
    Shi, Linyu
    Padilla, Byron
    Soliman, Ahmed M.
    McGonagle, Dennis
    DERMATOLOGY AND THERAPY, 2024, 14 (06) : 1517 - 1530
  • [3] Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis
    Proton Rahman
    Iain B. McInnes
    Atul Deodhar
    Georg Schett
    Phillip J. Mease
    May Shawi
    Daniel J. Cua
    Jonathan P. Sherlock
    Alexa P. Kollmeier
    Xie L. Xu
    Shihong Sheng
    Christopher T. Ritchlin
    Dennis McGonagle
    Clinical Rheumatology, 2024, 43 : 1591 - 1604
  • [4] Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis
    Rahman, Proton
    Mcinnes, Iain B.
    Deodhar, Atul
    Schett, Georg
    Mease, Phillip J.
    Shawi, May
    Cua, Daniel J.
    Sherlock, Jonathan P.
    Kollmeier, Alexa P.
    Xu, Xie L.
    Sheng, Shihong
    Ritchlin, Christopher T.
    McGonagle, Dennis
    CLINICAL RHEUMATOLOGY, 2024, 43 (05) : 1591 - 1604
  • [5] Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2
    Ostor, Andrew J. K.
    Soliman, Ahmed M.
    Papp, Kim A.
    Padilla, Byron
    Wang, Zailong
    Eldred, Ann
    de Vlam, Kurt
    Kivitz, Alan
    RMD OPEN, 2022, 8 (02):
  • [6] Synergistic Improvements in Synovitis, Enthesitis, and Patient-Reported Outcomes for Patients with Psoriatic Arthritis Treated with Ixekizumab in SPIRIT Trials
    Lars-Erik Kristensen
    Dennis McGonagle
    Martin Rudwaleit
    Hideto Kameda
    Peter Adler Würtzen
    Marcus Ngantcha
    Thorsten Holzkämper
    Josef Smolen
    Rheumatology and Therapy, 2025, 12 (2) : 381 - 395
  • [7] The effect of risankizumab on achieving minimal clinically important differences in patient-reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2
    Kristensen, L. E.
    Soliman, A. M.
    Papp, K.
    Barcomb, L.
    Eldred, A.
    Ostor, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) : 2120 - 2129
  • [8] Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies
    Ana-Maria Orbai
    Philip J. Mease
    Philip S. Helliwell
    Oliver FitzGerald
    Dona L. Fleishaker
    Rajiv Mundayat
    Pamela Young
    BMC Rheumatology, 6
  • [9] Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies
    Orbai, Ana-Maria
    Mease, Philip J.
    Helliwell, Philip S.
    FitzGerald, Oliver
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela
    BMC RHEUMATOLOGY, 2022, 6 (01)
  • [10] Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials
    Merola, Joseph F.
    Armstrong, April
    Khattri, Saakshi
    Paek, So Yeon
    Padilla, Byron
    Yue, Cuiyong
    Photowala, Huzefa
    Kaplan, Blair
    Kristensen, Lars Erik
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
12345